BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38410944)

  • 1. Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial.
    Ryan M; Ezad SM; Webb I; O'Kane PD; Dodd M; Evans R; Laidlaw L; Khan SQ; Weerackody R; Bagnall A; Panoulas VF; Rahman H; Strange JW; Fath-Ordoubadi F; Hoole SP; Stables RH; Curzen N; Clayton T; Perera D;
    Circ Cardiovasc Interv; 2024 Mar; 17(3):e013367. PubMed ID: 38410944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STICH3C: Rationale and Study Protocol.
    Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    van der Schaaf RJ; Claessen BE; Hoebers LP; Verouden NJ; Koolen JJ; Suttorp MJ; Barbato E; Bax M; Strauss BH; Olivecrona GK; Tuseth V; Glogar D; Råmunddal T; Tijssen JG; Piek JJ; Henriques JP;
    Trials; 2010 Sep; 11():89. PubMed ID: 20858263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
    Perera D; Stables R; Thomas M; Booth J; Pitt M; Blackman D; de Belder A; Redwood S;
    JAMA; 2010 Aug; 304(8):867-74. PubMed ID: 20736470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
    Perera D; Clayton T; Petrie MC; Greenwood JP; O'Kane PD; Evans R; Sculpher M; Mcdonagh T; Gershlick A; de Belder M; Redwood S; Carr-White G; Marber M;
    JACC Heart Fail; 2018 Jun; 6(6):517-526. PubMed ID: 29852933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial.
    Gao Y; Zhang F; Li C; Dai Y; Yang J; Qu Y; Qian J; Ge J;
    Trials; 2019 Mar; 20(1):162. PubMed ID: 30850023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.
    Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Kang TS; Gwon HC
    J Am Heart Assoc; 2023 May; 12(10):e029792. PubMed ID: 37158104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial.
    Calviño-Santos R; Estévez-Loureiro R; Peteiro-Vázquez J; Salgado-Fernández J; Rodríguez-Vilela A; Franco-Gutiérrez R; Bouzas-Mosquera A; Rodríguez-Fernández JÁ; Mesías-Prego A; González-Juanatey C; Aldama-López G; Piñón-Esteban P; Flores-Ríos X; Soler-Martín R; Seoane-Pillado T; Vázquez-González N; Muñiz J; Vázquez-Rodríguez JM
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e007924. PubMed ID: 31554422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Lüsebrink E; Kellnar A; Krieg K; Binzenhöfer L; Scherer C; Zimmer S; Schrage B; Fichtner S; Petzold T; Braun D; Peterss S; Brunner S; Hagl C; Westermann D; Hausleiter J; Massberg S; Thiele H; Schäfer A; Orban M
    Circulation; 2022 Apr; 145(16):1254-1284. PubMed ID: 35436135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.
    Chivardi C; Morgan H; Sculpher MJ; Clayton T; Evans R; Dodd M; Petrie M; Rinaldi CA; O'Kane P; Brown L; Perera D; Saramago P;
    Circ Cardiovasc Qual Outcomes; 2024 Jan; 17(1):e010533. PubMed ID: 37929587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.
    Farhan S; Vogel B; Montalescot G; Barthelemy O; Zeymer U; Desch S; de Waha-Thiele S; Maier LS; Sandri M; Akin I; Fuernau G; Ouarrak T; Hauguel-Moreau M; Schneider S; Thiele H; Huber K
    JAMA Cardiol; 2020 Dec; 5(12):1329-1337. PubMed ID: 32845312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Unloading Before Percutaneous Coronary Intervention is Associated With Improved Survival in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Miyashita S; Banlengchit R; Marbach JA; Chweich H; Kawabori M; Kimmelstiel CD; Kapur NK
    Cardiovasc Revasc Med; 2022 Jun; 39():28-35. PubMed ID: 34824038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of percutaneous left ventricular assist device in high-risk percutaneous coronary intervention and cardiogenic shock.
    Akhondi AB; Lee MS
    Rev Cardiovasc Med; 2013; 14(2-4):e144-9. PubMed ID: 24448256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Clinical and Functional Outcomes Be Improved with an Intelligent "Internet Plus"-Based Full Disease Cycle Remote Ischemic Conditioning Program in Acute ST-elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Rationale and Design of the i-RIC Trial.
    Zheng Y; Reinhardt JD; Li J; Hu D; Lin S; Wang L; Dai R; Fan Z; Ding R; Chen L; Yuan L; Xu Z; Cheng Y; Yan C; Zhang X; Wang L; Zhang X; Teng M; Yu Q; Yin A; Lu X;
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):45-57. PubMed ID: 32607820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK Trial.
    Sag CM; Zeymer U; Ouarrak T; Schneider S; Montalescot G; Huber K; Fuernau G; Freund A; Feistritzer HJ; Desch S; Thiele H; Maier LS
    Circ Cardiovasc Interv; 2020 Sep; 13(9):e009562. PubMed ID: 32883104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
    Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.